Autoimmunity Triggers in the NOD Mouse A Role for Natural Auto-antibody Reactivities in Type 1 Diabetes

被引:10
作者
Corte-Real, Joana [1 ]
Duarte, Nadia [1 ]
Tavares, Luis [2 ]
Penha-Goncalves, Carlos [1 ]
机构
[1] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal
[2] Fac Med Vet, CIISA, Lisbon, Portugal
来源
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY | 2009年 / 1173卷
关键词
type; 1; diabetes; NOD; natural auto-antibodies; GLUTAMIC-ACID DECARBOXYLASE; PANCREATIC BETA-CELLS; B-CELLS; MICE; INSULIN; EXPRESSION; RECEPTORS; DISEASE; EPITOPE; IGM;
D O I
10.1111/j.1749-6632.2009.04661.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The nonobese diabetic mouse (NOD) is widely used as a model to study human type I diabetes (T1D). In the NOD mouse T1D is a T cell-mediated autoimmune disease of complex etiology in which B cells play an essential role. One of the major unresolved issues in T1D is the genetic and/or environmental factors that trigger the autoimmune reaction. In the NOD mouse, as in humans, auto-antibodies to pancreatic islets are present at early ages and are highly correlated to diabetes progression, but their etiological role has long been disputed. NOD auto-antibodies have the characteristics of a natural repertoire, and B1 cells, the main natural antibody producers, exhibit functional differences in this strain that could have consequences for disease determination. Using a genetic approach, we propose to test if the NOD natural auto-antibody repertoire includes innate reactivities that participate in diabetes pathogenesis by promoting insulitis initiation.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 31 条
[1]   Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice [J].
Akashi, T ;
Nagafuchi, S ;
Anzai, K ;
Kondo, S ;
Kitamura, D ;
Wakana, S ;
Ono, J ;
Kikuchi, M ;
Niho, Y ;
Watanabe, T .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (08) :1159-1164
[2]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[3]   Prediction of IDDM in the general population - Strategies based on combinations of autoantibody markers [J].
Bingley, PJ ;
Bonifacio, E ;
Williams, AJK ;
Genovese, S ;
Bottazzo, GF ;
Gale, EAM .
DIABETES, 1997, 46 (11) :1701-1710
[4]   International workshop on lessons from animal models for human type 1 diabetes - Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice [J].
Bonifacio, E ;
Atkinson, M ;
Eisenbarth, G ;
Serreze, D ;
Kay, TWH ;
Lee-Chan, E ;
Singh, B .
DIABETES, 2001, 50 (11) :2451-2458
[5]   Moving towards efficient therapies in type 1 diabetes: To combine or not to combine? [J].
Bresson, D. ;
von Herrath, M. .
AUTOIMMUNITY REVIEWS, 2007, 6 (05) :315-322
[6]  
CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243
[7]   Natural autoantibodies [J].
Coutinho, A ;
Kazatchkine, MD ;
Avrameas, S .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (06) :812-818
[8]   Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential [J].
Dorshkind, Kenneth ;
Montecino-Rodriguez, Encarnacion .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (03) :213-219
[9]   Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response [J].
Ehrenstein, MR ;
O'Keefe, TL ;
Davies, SL ;
Neuberger, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10089-10093
[10]   POLYGENIC CONTROL OF AUTOIMMUNE DIABETES IN NONOBESE DIABETIC MICE [J].
GHOSH, S ;
PALMER, SM ;
RODRIGUES, NR ;
CORDELL, HJ ;
HEARNE, CM ;
CORNALL, RJ ;
PRINS, JB ;
MCSHANE, P ;
LATHROP, GM ;
PETERSON, LB ;
WICKER, LS ;
TODD, JA .
NATURE GENETICS, 1993, 4 (04) :404-409